Penn Pharma has appointed Edward Rowland as head of operational analytical services.
Joining the South Wales firm from Wyeth Research in Gosport, Hampshire, Rowland has 15 years’ experience in the pharmaceutical industry, being involved in r&d and commercial operations as well as analytical development roles. In his new position, he will be using his knowledge and operational expertise to manage a team of 45 analytical chemists.
Penn Pharma appointed two new directors, Richard Yarwood and David Cooper, earlier this month.
